首页 > 最新文献

Tropical Diseases, Travel Medicine and Vaccines最新文献

英文 中文
Transmission sources and severe rat lung worm diseases in travelers: a scoping review. 旅行者中的传播源和严重大鼠肺虫病:范围综述。
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2023-02-10 DOI: 10.1186/s40794-022-00184-4
Atibordee Meesing, Sittichai Khamsai, Kittisak Sawanyawisuth, Somsak Tiamkao, Wanchai Maleewong, Panita Limpawattana, Bundit Sawunyavisuth, Chetta Ngamjarus, Watchara Boonsawat

Background: Rat lung worm disease (RLWD) has several clinical forms including eosinophilic meningitis (EOM) and two severe forms, eosinophilic meningoencephalitis (EOME) and eosinophilic radiculomyelitis (EORM). It remains unclear whether transmission sources are associated with severe forms of RLWD. This study aimed to evaluate if transmission factors are related to the severity of RLWD among travelers by using a scoping review of case reports.

Methods: This was a review using five databases to retrieve case reports and case series of travelers with RLWD. Clinical data and transmission sources of reported cases diagnosed as RLWD were retrieved. The outcome of the study was occurrence of severe forms of RLWD defined as EOME, EORM, and combined EOME/EORM.

Results: We retrieved 1,326 articles from five databases and 31 articles were included in the analysis. There were 84 cases eligible from 15 countries. Four cases were excluded. Seventy cases were in EOM group and 10 cases had EOME or EORM. Compared with the EOM group, the EOME, EORM, and combination EOME/EORM group had similar age, sex, and risk factors of consumptions of apple snails, shrimp and prawn, and salad/vegetables. The EOME group had higher proportion of consumption of African snails than the EOM group (60% vs 13.8%). However, only one study reported the consumption of African snails and the heterogeneity between studies and the small sample size impeded direct comparisons between groups.

Conclusions: RLWD in travelers can be found in most continents and mostly get infected from endemic countries of RLWD. Further studies are required to evaluate the association between transmission vectors and severity of RLWD.

背景:大鼠肺蠕虫病(RLWD)有几种临床形式,包括嗜酸性粒细胞脑膜炎(EOM)和两种严重形式,嗜酸性粒细胞脑膜脑炎(EOME)和嗜酸性粒细胞神经根脊髓炎(EORM)。目前尚不清楚传播源是否与严重形式的RLWD有关。本研究旨在通过对病例报告进行范围审查,评估旅行者中RLWD的传播因素是否与严重程度有关。方法:利用5个数据库检索RLWD旅行者的病例报告和病例系列。检索诊断为RLWD的报告病例的临床资料和传播来源。研究结果为重度RLWD的发生,定义为EOME、EORM和EOME/EORM合并。结果:我们从5个数据库中检索到1326篇文献,其中31篇纳入分析。来自15个国家的84例符合条件的病例。4例被排除。EOM组70例,EOME或EORM组10例。与EOM组相比,EOME组、EORM组和EOME/EORM组合组在苹果蜗牛、对虾和沙拉/蔬菜的消费方面具有相似的年龄、性别和危险因素。EOME组食用非洲蜗牛的比例高于EOM组(60% vs 13.8%)。然而,只有一项研究报告了非洲蜗牛的消费量,研究之间的异质性和小样本量阻碍了组间的直接比较。结论:旅行者RLWD可在大多数大洲发现,主要来自RLWD流行国家。需要进一步的研究来评估传播媒介与RLWD严重程度之间的关系。
{"title":"Transmission sources and severe rat lung worm diseases in travelers: a scoping review.","authors":"Atibordee Meesing, Sittichai Khamsai, Kittisak Sawanyawisuth, Somsak Tiamkao, Wanchai Maleewong, Panita Limpawattana, Bundit Sawunyavisuth, Chetta Ngamjarus, Watchara Boonsawat","doi":"10.1186/s40794-022-00184-4","DOIUrl":"10.1186/s40794-022-00184-4","url":null,"abstract":"<p><strong>Background: </strong>Rat lung worm disease (RLWD) has several clinical forms including eosinophilic meningitis (EOM) and two severe forms, eosinophilic meningoencephalitis (EOME) and eosinophilic radiculomyelitis (EORM). It remains unclear whether transmission sources are associated with severe forms of RLWD. This study aimed to evaluate if transmission factors are related to the severity of RLWD among travelers by using a scoping review of case reports.</p><p><strong>Methods: </strong>This was a review using five databases to retrieve case reports and case series of travelers with RLWD. Clinical data and transmission sources of reported cases diagnosed as RLWD were retrieved. The outcome of the study was occurrence of severe forms of RLWD defined as EOME, EORM, and combined EOME/EORM.</p><p><strong>Results: </strong>We retrieved 1,326 articles from five databases and 31 articles were included in the analysis. There were 84 cases eligible from 15 countries. Four cases were excluded. Seventy cases were in EOM group and 10 cases had EOME or EORM. Compared with the EOM group, the EOME, EORM, and combination EOME/EORM group had similar age, sex, and risk factors of consumptions of apple snails, shrimp and prawn, and salad/vegetables. The EOME group had higher proportion of consumption of African snails than the EOM group (60% vs 13.8%). However, only one study reported the consumption of African snails and the heterogeneity between studies and the small sample size impeded direct comparisons between groups.</p><p><strong>Conclusions: </strong>RLWD in travelers can be found in most continents and mostly get infected from endemic countries of RLWD. Further studies are required to evaluate the association between transmission vectors and severity of RLWD.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"9 1","pages":"2"},"PeriodicalIF":2.4,"publicationDate":"2023-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912548/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10693091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuropathology of yellow fever autopsy cases. 黄热病尸检病例的神经病理学分析。
IF 3.1 Q3 INFECTIOUS DISEASES Pub Date : 2023-01-15 DOI: 10.1186/s40794-022-00187-1
Fernando Pereira Frassetto, Sergio Rosemberg

Background: Yellow fever is a viral hemorrhagic fever caused by yellow fever virus, a mosquito-borne flavivirus. Despite an effective vaccine, major outbreaks continue to occur around the world. Even though it is not a proven neurotropic virus, neurological symptoms in more severe clinical forms are frequent. The understanding of this apparent paradox is still rarely addressed in literature.

Methods: The brains of thirty-eight patients with yellow fever confirmed by RT-PCR, who underwent autopsy, were analyzed morphologically to identify and characterize neuropathological changes. The data were compared with brains collected from individuals without the disease, as a control group. Both cases and controls were subdivided according to the presence or absence of co-concurrent septic shock, to exclude changes of the sepsis associated encephalopathy. To verify possible morphological differences between the yellow fever cases groups, between the control groups, and between the cases and the controls, we applied the statistical tests Fisher's exact test and chi-square, with p values < 0.05 considered statistically significant.

Results: All cases and controls presented, at least focally, neuropathological changes, which included edema, meningeal and parenchymal inflammatory infiltrate and hemorrhages, and perivascular inflammatory infiltrate. We did not find an unequivocal aspect of encephalitis. The only parameter that, after statistical analysis, can be attributed to yellow fever was the perivascular inflammatory infiltrate.

Conclusions: The neuropathological findings are sufficient to justify the multiple clinical neurologic disturbances detected in the YF cases. Since most of the parameters evaluated did not show statistically significant difference between cases and controls, an explanation for most of the neuropathological findings may be the vascular changes, consequent to shock induced endotheliopathy, associated with stimulation of the immune system inherent to systemic infectious processes. The statistical difference obtained in yellow fever cases regarding perivascular infiltrate can be can be explained by the immune activation inherent to the condition.

背景:黄热病是由黄热病病毒(一种蚊媒黄病毒)引起的病毒性出血热。尽管有有效的疫苗,但世界各地继续发生重大疫情。尽管它不是一种被证实的嗜神经病毒,但更严重的临床形式的神经症状是常见的。对这个明显的悖论的理解在文学中仍然很少被提及。方法:对尸检的38例经RT-PCR证实的黄热病患者的脑组织进行形态学分析,以识别和表征神经病理变化。研究人员将这些数据与未患病个体的大脑数据作为对照组进行了比较。根据有无并发脓毒症休克对病例和对照组进行细分,以排除脓毒症相关脑病的变化。为了验证黄热病病例组之间、对照组之间以及病例与对照组之间可能存在的形态学差异,我们应用统计学检验Fisher精确检验和卡方检验,p值。结果:所有病例和对照组至少表现出局部神经病理改变,包括水肿、脑膜和实质炎症浸润和出血,以及血管周围炎症浸润。我们没有发现脑炎的明确方面。经过统计分析,唯一可以归因于黄热病的参数是血管周围炎症浸润。结论:神经病理学结果足以证明YF病例中发现的多种临床神经障碍。由于评估的大多数参数在病例和对照组之间没有统计学上的显著差异,大多数神经病理结果的解释可能是血管改变,这是休克诱导的内皮病的结果,与全身感染过程固有的免疫系统刺激有关。在黄热病病例中获得的关于血管周围浸润的统计差异可以用该疾病固有的免疫激活来解释。
{"title":"Neuropathology of yellow fever autopsy cases.","authors":"Fernando Pereira Frassetto,&nbsp;Sergio Rosemberg","doi":"10.1186/s40794-022-00187-1","DOIUrl":"https://doi.org/10.1186/s40794-022-00187-1","url":null,"abstract":"<p><strong>Background: </strong>Yellow fever is a viral hemorrhagic fever caused by yellow fever virus, a mosquito-borne flavivirus. Despite an effective vaccine, major outbreaks continue to occur around the world. Even though it is not a proven neurotropic virus, neurological symptoms in more severe clinical forms are frequent. The understanding of this apparent paradox is still rarely addressed in literature.</p><p><strong>Methods: </strong>The brains of thirty-eight patients with yellow fever confirmed by RT-PCR, who underwent autopsy, were analyzed morphologically to identify and characterize neuropathological changes. The data were compared with brains collected from individuals without the disease, as a control group. Both cases and controls were subdivided according to the presence or absence of co-concurrent septic shock, to exclude changes of the sepsis associated encephalopathy. To verify possible morphological differences between the yellow fever cases groups, between the control groups, and between the cases and the controls, we applied the statistical tests Fisher's exact test and chi-square, with p values < 0.05 considered statistically significant.</p><p><strong>Results: </strong>All cases and controls presented, at least focally, neuropathological changes, which included edema, meningeal and parenchymal inflammatory infiltrate and hemorrhages, and perivascular inflammatory infiltrate. We did not find an unequivocal aspect of encephalitis. The only parameter that, after statistical analysis, can be attributed to yellow fever was the perivascular inflammatory infiltrate.</p><p><strong>Conclusions: </strong>The neuropathological findings are sufficient to justify the multiple clinical neurologic disturbances detected in the YF cases. Since most of the parameters evaluated did not show statistically significant difference between cases and controls, an explanation for most of the neuropathological findings may be the vascular changes, consequent to shock induced endotheliopathy, associated with stimulation of the immune system inherent to systemic infectious processes. The statistical difference obtained in yellow fever cases regarding perivascular infiltrate can be can be explained by the immune activation inherent to the condition.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"9 1","pages":"1"},"PeriodicalIF":3.1,"publicationDate":"2023-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883951/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10626031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The use of rotational thromboelastometry parameters in understanding the coagulopathy following hump-nosed viper (Hypnale spp) bites: a preliminary study. 使用旋转血栓弹性测量参数在了解后凝血病驼鼻毒蛇(Hypnale spp)咬:初步研究。
IF 3.1 Q3 INFECTIOUS DISEASES Pub Date : 2023-01-02 DOI: 10.1186/s40794-022-00186-2
Bhawani Yasassri Alvitigala, Lallindra Viranjan Gooneratne, Iresha Dharmasena, Nuwan Premawardana, Manujasri Wimalachandra, Miyuru Weerarathna, Roopen Arya, Ariaranee Gnanathasan

Background: Hump-nosed vipers (HNV; Hypnale spp) are one of the medically important venomous snakes in Sri Lanka and South-Western regions of India. The haemostatic dysfunction due to HNV bites is poorly characterized by standard diagnostic tests performed to identify coagulopathy. We aimed to determine the usefulness of rotational thromboelastometry (ROTEM) parameters compared to 20-minute whole blood clotting test (WBCT20) and prothrombin time (PT) in understanding the coagulopathy of HNV bites.

Methods: Twenty-three HNV snakebite patients in a prospective study of 127 consecutive snakebites were recruited. After recording details of the clinical presentation, PT/international normalized ratio (INR), WBCT20 and ROTEM delta were performed at presentation.

Results: In this preliminary study, none of the patients had clinically apparent bleeding. Coagulopathy was detected by either WBCT20, INR or ROTEM in 13 HNV patients. Eleven had a coagulopathy detectable by ROTEM (either abnormal EXTEM-CT, INTEM-CT or FIBTEM-MCF) but with negative WBCT20. Of them, only two had prolonged INR values. Two patients had positive WBCT20 but with normal ROTEM and INR values. The remaining 10 patients did not show any coagulopathy either by INR, ROTEM or WBCT20.

Conclusion: In this preliminary study with small number of sample size, ROTEM parameters appeared to be more sensitive to subtle changes in coagulation compared to WBCT20. The clinical utility of detecting these changes and their usefulness in managing snakebite should be explored further in a larger study.

背景:驼鼻毒蛇(HNV;是斯里兰卡和印度西南部地区重要的医学毒蛇之一。由HNV咬伤引起的止血功能障碍很难通过标准诊断测试来确定凝血功能障碍。我们的目的是确定旋转血栓弹性测量(ROTEM)参数与20分钟全血凝血试验(WBCT20)和凝血酶原时间(PT)在了解HNV咬伤的凝血功能方面的有效性。方法:在前瞻性研究中,连续127例蛇咬伤患者中招募23例HNV蛇咬伤患者。在记录临床表现细节后,在表现时进行PT/international normalized ratio (INR)、WBCT20和ROTEM delta。结果:本组患者均无临床明显出血。13例HNV患者采用WBCT20、INR或ROTEM检测凝血功能。11例ROTEM检测到凝血功能障碍(EXTEM-CT、intertem - ct或FIBTEM-MCF异常),但WBCT20阴性。其中,只有两个国家的印度卢比升值时间较长。2例患者WBCT20阳性,但ROTEM和INR值正常。其余10例患者通过INR、ROTEM或WBCT20均未表现出凝血功能障碍。结论:在本小样本量的初步研究中,ROTEM参数比WBCT20对凝血的细微变化更为敏感。检测这些变化的临床应用及其在处理蛇咬伤中的有用性应在更大的研究中进一步探讨。
{"title":"The use of rotational thromboelastometry parameters in understanding the coagulopathy following hump-nosed viper (Hypnale spp) bites: a preliminary study.","authors":"Bhawani Yasassri Alvitigala,&nbsp;Lallindra Viranjan Gooneratne,&nbsp;Iresha Dharmasena,&nbsp;Nuwan Premawardana,&nbsp;Manujasri Wimalachandra,&nbsp;Miyuru Weerarathna,&nbsp;Roopen Arya,&nbsp;Ariaranee Gnanathasan","doi":"10.1186/s40794-022-00186-2","DOIUrl":"https://doi.org/10.1186/s40794-022-00186-2","url":null,"abstract":"<p><strong>Background: </strong>Hump-nosed vipers (HNV; Hypnale spp) are one of the medically important venomous snakes in Sri Lanka and South-Western regions of India. The haemostatic dysfunction due to HNV bites is poorly characterized by standard diagnostic tests performed to identify coagulopathy. We aimed to determine the usefulness of rotational thromboelastometry (ROTEM) parameters compared to 20-minute whole blood clotting test (WBCT20) and prothrombin time (PT) in understanding the coagulopathy of HNV bites.</p><p><strong>Methods: </strong>Twenty-three HNV snakebite patients in a prospective study of 127 consecutive snakebites were recruited. After recording details of the clinical presentation, PT/international normalized ratio (INR), WBCT20 and ROTEM delta were performed at presentation.</p><p><strong>Results: </strong>In this preliminary study, none of the patients had clinically apparent bleeding. Coagulopathy was detected by either WBCT20, INR or ROTEM in 13 HNV patients. Eleven had a coagulopathy detectable by ROTEM (either abnormal EXTEM-CT, INTEM-CT or FIBTEM-MCF) but with negative WBCT20. Of them, only two had prolonged INR values. Two patients had positive WBCT20 but with normal ROTEM and INR values. The remaining 10 patients did not show any coagulopathy either by INR, ROTEM or WBCT20.</p><p><strong>Conclusion: </strong>In this preliminary study with small number of sample size, ROTEM parameters appeared to be more sensitive to subtle changes in coagulation compared to WBCT20. The clinical utility of detecting these changes and their usefulness in managing snakebite should be explored further in a larger study.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"8 1","pages":"28"},"PeriodicalIF":3.1,"publicationDate":"2023-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806870/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10532669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Plasmodium vivax: the potential obstacles it presents to malaria elimination and eradication. 间日疟原虫:消除和根除疟疾的潜在障碍。
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2022-12-15 DOI: 10.1186/s40794-022-00185-3
Kassahun Habtamu, Beyene Petros, Guiyun Yan

Initiatives to eradicate malaria have a good impact on P. falciparum malaria worldwide. P. vivax, however, still presents significant difficulties. This is due to its unique biological traits, which, in comparison to P. falciparum, pose serious challenges for malaria elimination approaches. P. vivax's numerous distinctive characteristics and its ability to live for weeks to years in liver cells in its hypnozoite form, which may elude the human immune system and blood-stage therapy and offer protection during mosquito-free seasons. Many malaria patients are not fully treated because of contraindications to primaquine use in pregnant and nursing women and are still vulnerable to P. vivax relapses, although there are medications that could radical cure P. vivax. Additionally, due to CYP2D6's highly variable genetic polymorphism, the pharmacokinetics of primaquine may be impacted. Due to their inability to metabolize PQ, some CYP2D6 polymorphism alleles can cause patients to not respond to treatment. Tafenoquine offers a radical treatment in a single dose that overcomes the potentially serious problem of poor adherence to daily primaquine. Despite this benefit, hemolysis of the early erythrocytes continues in individuals with G6PD deficiency until all susceptible cells have been eliminated. Field techniques such as microscopy or rapid diagnostic tests (RDTs) miss the large number of submicroscopic and/or asymptomatic infections brought on by reticulocyte tropism and the low parasitemia levels that accompany it. Moreover, P. vivax gametocytes grow more quickly and are much more prevalent in the bloodstream. P. vivax populations also have a great deal of genetic variation throughout their genome, which ensures evolutionary fitness and boosts adaptation potential. Furthermore, P. vivax fully develops in the mosquito faster than P. falciparum. These characteristics contribute to parasite reservoirs in the human population and facilitate faster transmission. Overall, no genuine chance of eradication is predicted in the next few years unless new tools for lowering malaria transmission are developed (i.e., malaria elimination and eradication). The challenging characteristics of P. vivax that impede the elimination and eradication of malaria are thus discussed in this article.

根除疟疾的举措对全世界恶性疟原虫疟疾产生了良好影响。然而,间日疟原虫仍然存在重大困难。这是由于其独特的生物学特性,与恶性疟原虫相比,这对消除疟疾的方法构成了严重挑战。间日疟原虫有许多独特的特征,它能够以裂殖细胞的形式在肝细胞中存活数周至数年,这可能会躲避人类免疫系统和血液阶段的治疗,并在无蚊季节提供保护。许多疟疾患者由于孕妇和哺乳期妇女使用伯氨喹的禁忌症而没有得到充分治疗,并且仍然容易复发间日疟原虫,尽管有药物可以彻底治愈间日疟原虫。此外,由于CYP2D6高度可变的遗传多态性,伯氨喹的药代动力学可能会受到影响。由于不能代谢PQ,一些CYP2D6多态性等位基因会导致患者对治疗没有反应。Tafenoquine提供了一种单剂量的根治性治疗,克服了每日使用伯氨喹依从性差的潜在严重问题。尽管有这种益处,G6PD缺乏症患者的早期红细胞溶血仍在继续,直到所有易感细胞都被消除。显微镜或快速诊断测试(RDT)等现场技术忽略了网织红细胞向性和伴随而来的低寄生虫血症水平所带来的大量亚微观和/或无症状感染。此外,间日疟原虫配子细胞生长更快,在血液中更为普遍。间日疟原虫种群在整个基因组中也有大量的遗传变异,这确保了进化适应性并提高了适应潜力。此外,间日疟原虫在蚊子体内的发育速度比恶性疟原虫快。这些特征有助于人类体内的寄生虫库,并促进更快的传播。总的来说,除非开发出降低疟疾传播的新工具(即消除和根除疟疾),否则预计在未来几年内不会有真正的根除机会。因此,本文讨论了间日疟原虫阻碍消除和根除疟疾的挑战性特征。
{"title":"Plasmodium vivax: the potential obstacles it presents to malaria elimination and eradication.","authors":"Kassahun Habtamu, Beyene Petros, Guiyun Yan","doi":"10.1186/s40794-022-00185-3","DOIUrl":"10.1186/s40794-022-00185-3","url":null,"abstract":"<p><p>Initiatives to eradicate malaria have a good impact on P. falciparum malaria worldwide. P. vivax, however, still presents significant difficulties. This is due to its unique biological traits, which, in comparison to P. falciparum, pose serious challenges for malaria elimination approaches. P. vivax's numerous distinctive characteristics and its ability to live for weeks to years in liver cells in its hypnozoite form, which may elude the human immune system and blood-stage therapy and offer protection during mosquito-free seasons. Many malaria patients are not fully treated because of contraindications to primaquine use in pregnant and nursing women and are still vulnerable to P. vivax relapses, although there are medications that could radical cure P. vivax. Additionally, due to CYP2D6's highly variable genetic polymorphism, the pharmacokinetics of primaquine may be impacted. Due to their inability to metabolize PQ, some CYP2D6 polymorphism alleles can cause patients to not respond to treatment. Tafenoquine offers a radical treatment in a single dose that overcomes the potentially serious problem of poor adherence to daily primaquine. Despite this benefit, hemolysis of the early erythrocytes continues in individuals with G6PD deficiency until all susceptible cells have been eliminated. Field techniques such as microscopy or rapid diagnostic tests (RDTs) miss the large number of submicroscopic and/or asymptomatic infections brought on by reticulocyte tropism and the low parasitemia levels that accompany it. Moreover, P. vivax gametocytes grow more quickly and are much more prevalent in the bloodstream. P. vivax populations also have a great deal of genetic variation throughout their genome, which ensures evolutionary fitness and boosts adaptation potential. Furthermore, P. vivax fully develops in the mosquito faster than P. falciparum. These characteristics contribute to parasite reservoirs in the human population and facilitate faster transmission. Overall, no genuine chance of eradication is predicted in the next few years unless new tools for lowering malaria transmission are developed (i.e., malaria elimination and eradication). The challenging characteristics of P. vivax that impede the elimination and eradication of malaria are thus discussed in this article.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"8 1","pages":"27"},"PeriodicalIF":2.4,"publicationDate":"2022-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753897/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10608072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19: how can travel medicine benefit from tourism's focus on people during a pandemic? COVID-19:在大流行病期间,旅游医学如何从旅游业对人的关注中获益?
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2022-12-01 DOI: 10.1186/s40794-022-00182-6
Irmgard L Bauer

In 2020, COVID-19 affected every aspect of life around the globe. The spread of SARS-CoV-2 through travel led to lockdowns, travel bans and border closures, crippling the tourism industry. Without tourists, there would be no tourism industry-and no travel medicine. Therefore, scholars started to research the human aspect of tourism immediately to develop strategies for economic recovery. The resulting insights are useful for travel medicine not only to see how tourism dealt with a medical crisis but also to understand travellers better who may be seeking health advice during and after a pandemic.This article presents tourism research of 2020 covering risk perception and travel intentions including mass-gatherings, the use of technology to protect from infection, impacts on tourism workers, residents' reactions to potentially infected travellers, discrimination, and racism. A potential fork in the road to tourism's future may have implications for travel health practitioners. Research recommendations conclude the paper. Understanding the industry response during the early days of panic and uncertainty may help prepare not only appropriate guidelines for travellers but also clearer instructions for tourism, transportation, and hospitality in anticipation of the next pandemic.

2020 年,COVID-19 影响了全球生活的方方面面。通过旅行传播的 SARS-CoV-2 导致了封锁、旅行禁令和边境关闭,使旅游业陷入瘫痪。没有游客,就没有旅游业,也就没有旅游医药。因此,学者们立即开始研究旅游业的人文因素,以制定经济复苏战略。本文介绍了 2020 年的旅游业研究,内容涉及风险认知和旅行意向,包括大规模集会、使用技术防止感染、对旅游从业人员的影响、居民对可能受感染的游客的反应、歧视和种族主义。旅游业未来可能出现的岔路口可能会对旅游保健从业人员产生影响。本文最后提出了研究建议。在恐慌和不确定的早期,了解旅游业的反应不仅有助于为旅客制定适当的指南,还有助于为旅游业、运输业和酒店业制定更明确的指示,以应对下一次大流行。
{"title":"COVID-19: how can travel medicine benefit from tourism's focus on people during a pandemic?","authors":"Irmgard L Bauer","doi":"10.1186/s40794-022-00182-6","DOIUrl":"10.1186/s40794-022-00182-6","url":null,"abstract":"<p><p>In 2020, COVID-19 affected every aspect of life around the globe. The spread of SARS-CoV-2 through travel led to lockdowns, travel bans and border closures, crippling the tourism industry. Without tourists, there would be no tourism industry-and no travel medicine. Therefore, scholars started to research the human aspect of tourism immediately to develop strategies for economic recovery. The resulting insights are useful for travel medicine not only to see how tourism dealt with a medical crisis but also to understand travellers better who may be seeking health advice during and after a pandemic.This article presents tourism research of 2020 covering risk perception and travel intentions including mass-gatherings, the use of technology to protect from infection, impacts on tourism workers, residents' reactions to potentially infected travellers, discrimination, and racism. A potential fork in the road to tourism's future may have implications for travel health practitioners. Research recommendations conclude the paper. Understanding the industry response during the early days of panic and uncertainty may help prepare not only appropriate guidelines for travellers but also clearer instructions for tourism, transportation, and hospitality in anticipation of the next pandemic.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"8 1","pages":"26"},"PeriodicalIF":2.4,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713119/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10678639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of vaccination against Covid-19 one year after its introduction in Brazil. 在巴西引入 Covid-19 疫苗一年后的效果。
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2022-11-18 DOI: 10.1186/s40794-022-00183-5
Jadher Percio, Cibelle Mendes Cabral, Francieli Fontana Sutile Tardetti Fantinato, Dalva Maria de Assis, Lely Stella Guzmán-Barrera, Wildo Navegantes de Araújo

Background: Worldwide, several efforts have been made to develop, distribute and administer safe and effective vaccines to reduce morbidity and mortality and control the Covid-19 pandemic. This study aimed to analyze the effect of vaccination against Covid-19, one year after its introduction in Brazil.

Methods: An ecological study that analyzed the general effect of vaccination against Covid-19 on disease morbidity and mortality indicators among the Brazilian population aged 18 years or older per epidemiological week (EW), comparing the pre and postvaccination period. Morbidity and mortality indicators were calculated from secondary databases (hospitalization rate, severity, case fatality rate and mortality) and vaccination coverage by age groups (18 to 59 years and 60 years or older). Morbimortality trends were estimated using the JoinPoint model and their association with vaccine coverage using the Poisson model.

Results: The average weekly percentage change (AWPC) of morbidity and mortality indicators reduced after the introduction of Covid-19 vaccination: hospitalization rate (from 15.3% to -6.0%), severity (from 0.4% to -0.2%), case fatality rate (from 0.3% to -0.2%) and mortality (from 20.5% to -4.3%). The following indicators were inversely associated with the increase in vaccine coverage against Covid-19: hospitalization (IRR: 0.974), mortality (IRR: 0.975) and lethality for people aged 60 years or older (IRR: 0.997).

Conclusions: In spite of the three epidemic waves and the circulation of variants of concern, the general effect of vaccination against Covid-19 in reducing the trend of morbidity and mortality from the disease in Brazil was demonstrated. These findings contribute to a better understanding of the mass vaccination program against Covid-19 and may inform future public health policies.

背景:全世界都在努力开发、分发和接种安全有效的疫苗,以降低发病率和死亡率,控制 Covid-19 的流行。本研究旨在分析 Covid-19 疫苗在巴西上市一年后的效果:这是一项生态学研究,分析了接种Covid-19疫苗对巴西18岁及以上人群每流行病周(EW)发病率和死亡率指标的总体影响,并对接种前后进行了比较。发病率和死亡率指标是通过二级数据库(住院率、严重程度、病死率和死亡率)和按年龄组(18 至 59 岁和 60 岁或以上)划分的疫苗接种覆盖率计算得出的。采用 JoinPoint 模型估算了死亡率趋势,并采用泊松模型估算了死亡率趋势与疫苗接种率的关系:结果:接种 Covid-19 疫苗后,发病率和死亡率指标的平均每周百分比变化(AWPC)有所下降:住院率(从 15.3% 降至 -6.0%)、严重程度(从 0.4% 降至 -0.2%)、病死率(从 0.3% 降至 -0.2%)和死亡率(从 20.5% 降至 -4.3%)。以下指标与 Covid-19 疫苗覆盖率的提高成反比:住院率(IRR:0.974)、死亡率(IRR:0.975)和 60 岁或以上人群的致死率(IRR:0.997):结论:尽管经历了三次流行病浪潮和令人担忧的变种的传播,但接种 Covid-19 疫苗在降低巴西该疾病的发病率和死亡率方面的总体效果得到了证实。这些研究结果有助于更好地理解大规模 Covid-19 疫苗接种计划,并为未来的公共卫生政策提供参考。
{"title":"Effect of vaccination against Covid-19 one year after its introduction in Brazil.","authors":"Jadher Percio, Cibelle Mendes Cabral, Francieli Fontana Sutile Tardetti Fantinato, Dalva Maria de Assis, Lely Stella Guzmán-Barrera, Wildo Navegantes de Araújo","doi":"10.1186/s40794-022-00183-5","DOIUrl":"10.1186/s40794-022-00183-5","url":null,"abstract":"<p><strong>Background: </strong>Worldwide, several efforts have been made to develop, distribute and administer safe and effective vaccines to reduce morbidity and mortality and control the Covid-19 pandemic. This study aimed to analyze the effect of vaccination against Covid-19, one year after its introduction in Brazil.</p><p><strong>Methods: </strong>An ecological study that analyzed the general effect of vaccination against Covid-19 on disease morbidity and mortality indicators among the Brazilian population aged 18 years or older per epidemiological week (EW), comparing the pre and postvaccination period. Morbidity and mortality indicators were calculated from secondary databases (hospitalization rate, severity, case fatality rate and mortality) and vaccination coverage by age groups (18 to 59 years and 60 years or older). Morbimortality trends were estimated using the JoinPoint model and their association with vaccine coverage using the Poisson model.</p><p><strong>Results: </strong>The average weekly percentage change (AWPC) of morbidity and mortality indicators reduced after the introduction of Covid-19 vaccination: hospitalization rate (from 15.3% to -6.0%), severity (from 0.4% to -0.2%), case fatality rate (from 0.3% to -0.2%) and mortality (from 20.5% to -4.3%). The following indicators were inversely associated with the increase in vaccine coverage against Covid-19: hospitalization (IRR: 0.974), mortality (IRR: 0.975) and lethality for people aged 60 years or older (IRR: 0.997).</p><p><strong>Conclusions: </strong>In spite of the three epidemic waves and the circulation of variants of concern, the general effect of vaccination against Covid-19 in reducing the trend of morbidity and mortality from the disease in Brazil was demonstrated. These findings contribute to a better understanding of the mass vaccination program against Covid-19 and may inform future public health policies.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"8 1","pages":"25"},"PeriodicalIF":2.4,"publicationDate":"2022-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675092/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10424615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Misdiagnosis and inappropriate treatment of cutaneous leishmaniasis: a case report. 皮肤利什曼病误诊与治疗不当1例报告。
IF 3.1 Q3 INFECTIOUS DISEASES Pub Date : 2022-08-01 DOI: 10.1186/s40794-022-00175-5
Katarzyna Sikorska, Marta Gesing, Romuald Olszański, Anna Roszko-Wysokińska, Beata Szostakowska, Katarzyna Van Damme-Ostapowicz

Background: Leishmaniasis is a widespread disease in tropical and subtropical countries, except for Australia and Oceania. In Poland, tourists, migrants and travellers from leishmaniasis-endemic countries may carry Leishmania.

Case presentation: We present a case of undiagnosed cutaneous leishmaniasis in a patient who received many weeks of inadequate antibiotic treatment. Ulceration in the right submandibular region was thought to be a purulent complication after laser surgery. Six weeks before the ulcer developed, the patient had visited the jungle (Guatemala). Cutaneous leishmaniasis was finally diagnosed after nine months based on a proper history and a polymerase chain reaction (PCR) assay. Treatment with antimony derivatives was administered. After three months, the ulcer healed but left a scar.

Conclusion: A lack of knowledge about tropical diseases among doctors and an incomplete medical history were the reasons for many weeks of erroneous treatment of cutaneous leishmaniasis with antibiotics. This is the first reported case of cutaneous leishmaniasis misdiagnosed as a complication after an aesthetic medical procedure.

背景:利什曼病是除澳大利亚和大洋洲外热带和亚热带国家的一种广泛流行的疾病。在波兰,来自利什曼病流行国家的游客、移民和旅行者可能携带利什曼病。病例介绍:我们提出了一例未确诊的皮肤利什曼病患者谁接受了许多周的抗生素治疗不足。右下颌骨区域溃疡被认为是激光手术后的化脓性并发症。溃疡发生前6周,患者曾去过丛林(危地马拉)。9个月后,根据适当的病史和聚合酶链反应(PCR)测定,最终诊断为皮肤利什曼病。给予锑衍生物治疗。三个月后,溃疡愈合了,但留下了疤痕。结论:医生对热带病知识的缺乏和病史的不完整是导致皮肤利什曼病抗生素治疗错误数周的原因。这是首例报道的皮肤利什曼病误诊为并发症后的美容医疗程序。
{"title":"Misdiagnosis and inappropriate treatment of cutaneous leishmaniasis: a case report.","authors":"Katarzyna Sikorska,&nbsp;Marta Gesing,&nbsp;Romuald Olszański,&nbsp;Anna Roszko-Wysokińska,&nbsp;Beata Szostakowska,&nbsp;Katarzyna Van Damme-Ostapowicz","doi":"10.1186/s40794-022-00175-5","DOIUrl":"https://doi.org/10.1186/s40794-022-00175-5","url":null,"abstract":"<p><strong>Background: </strong>Leishmaniasis is a widespread disease in tropical and subtropical countries, except for Australia and Oceania. In Poland, tourists, migrants and travellers from leishmaniasis-endemic countries may carry Leishmania.</p><p><strong>Case presentation: </strong>We present a case of undiagnosed cutaneous leishmaniasis in a patient who received many weeks of inadequate antibiotic treatment. Ulceration in the right submandibular region was thought to be a purulent complication after laser surgery. Six weeks before the ulcer developed, the patient had visited the jungle (Guatemala). Cutaneous leishmaniasis was finally diagnosed after nine months based on a proper history and a polymerase chain reaction (PCR) assay. Treatment with antimony derivatives was administered. After three months, the ulcer healed but left a scar.</p><p><strong>Conclusion: </strong>A lack of knowledge about tropical diseases among doctors and an incomplete medical history were the reasons for many weeks of erroneous treatment of cutaneous leishmaniasis with antibiotics. This is the first reported case of cutaneous leishmaniasis misdiagnosed as a complication after an aesthetic medical procedure.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"8 1","pages":"18"},"PeriodicalIF":3.1,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341103/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9181951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Dynamics of dengue and SARS-COV-2 co-infection in an endemic area of Colombia 哥伦比亚某流行地区登革热和SARS-COV-2合并感染动态
IF 3.1 Q3 INFECTIOUS DISEASES Pub Date : 2022-05-15 DOI: 10.1186/s40794-022-00169-3
Tomás Acosta-Pérez, Tomás Rodríguez-Yánez, Amilkar J Almanza-Hurtado, M. C. Martínez-Ávila, Carmelo Dueñas-Castell
{"title":"Dynamics of dengue and SARS-COV-2 co-infection in an endemic area of Colombia","authors":"Tomás Acosta-Pérez, Tomás Rodríguez-Yánez, Amilkar J Almanza-Hurtado, M. C. Martínez-Ávila, Carmelo Dueñas-Castell","doi":"10.1186/s40794-022-00169-3","DOIUrl":"https://doi.org/10.1186/s40794-022-00169-3","url":null,"abstract":"","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2022-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43017747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Infectious diseases and predominant travel-related syndromes among long-term expatriates living in low-and middle- income countries: a scoping review. 居住在中低收入国家的长期外籍人士的传染病和主要旅行相关综合征:范围界定综述
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2022-05-01 DOI: 10.1186/s40794-022-00168-4
Amornphat Kitro, Thundon Ngamprasertchai, Kriengkrai Srithanaviboonchai

Introduction: Expatriates working in low-and middle-income countries have unique health problems. Migration leads not only to an increase in individual health risk but also a risk of global impact, such as pandemics. Expatriates with no prior experience living in tropical settings have expressed greatest concern about infectious diseases and appropriate peri-travel consultation is essential to expatriates. The objective of this review is to describe infections and travel-related syndromes among expatriates living in low-and middle-income countries.

Methods: MEDLINE database since the year 2000 was searched for relevant literature. Search terms were "long-term travel", "expatriate", and "health problems". The additional references were obtained from hand-searching of selected articles.

Results: Up to 80% of expatriates suffered from gastrointestinal problems followed by dermatologic problems (up to 40%), and febrile systemic infection/vector-borne/parasitic infection (up to 34%) Expatriates living in Southeast Asia were at risk of vector-borne diseases including dengue and non-Plasmodium falciparum (pf) malaria while expatriates living in South Asia had a high prevalence of acute and chronic diarrhea. Staying long-term in Africa was related to an elevated risk for pf malaria and gastrointestinal infection. In Latin America, dermatologic problems were commonly reported illnesses among expatriates.

Conclusion: Certain health risks for expatriates who are going to depart to specific regions should be the focus of pre-travel consultation. Specific health preparations may reduce the risk of disease throughout their time abroad. Disease and symptom awareness is essential for screening, early diagnosis, and better health outcomes for ill-expatriates.

{"title":"Infectious diseases and predominant travel-related syndromes among long-term expatriates living in low-and middle- income countries: a scoping review.","authors":"Amornphat Kitro, Thundon Ngamprasertchai, Kriengkrai Srithanaviboonchai","doi":"10.1186/s40794-022-00168-4","DOIUrl":"10.1186/s40794-022-00168-4","url":null,"abstract":"<p><strong>Introduction: </strong>Expatriates working in low-and middle-income countries have unique health problems. Migration leads not only to an increase in individual health risk but also a risk of global impact, such as pandemics. Expatriates with no prior experience living in tropical settings have expressed greatest concern about infectious diseases and appropriate peri-travel consultation is essential to expatriates. The objective of this review is to describe infections and travel-related syndromes among expatriates living in low-and middle-income countries.</p><p><strong>Methods: </strong>MEDLINE database since the year 2000 was searched for relevant literature. Search terms were \"long-term travel\", \"expatriate\", and \"health problems\". The additional references were obtained from hand-searching of selected articles.</p><p><strong>Results: </strong>Up to 80% of expatriates suffered from gastrointestinal problems followed by dermatologic problems (up to 40%), and febrile systemic infection/vector-borne/parasitic infection (up to 34%) Expatriates living in Southeast Asia were at risk of vector-borne diseases including dengue and non-Plasmodium falciparum (pf) malaria while expatriates living in South Asia had a high prevalence of acute and chronic diarrhea. Staying long-term in Africa was related to an elevated risk for pf malaria and gastrointestinal infection. In Latin America, dermatologic problems were commonly reported illnesses among expatriates.</p><p><strong>Conclusion: </strong>Certain health risks for expatriates who are going to depart to specific regions should be the focus of pre-travel consultation. Specific health preparations may reduce the risk of disease throughout their time abroad. Disease and symptom awareness is essential for screening, early diagnosis, and better health outcomes for ill-expatriates.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":" ","pages":"11"},"PeriodicalIF":2.4,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057062/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45612387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adherence to WHO vaccine storage codes and vaccine cold chain management practices at primary healthcare facilities in Dalocha District of Silt'e Zone, Ethiopia 遵守世界卫生组织疫苗储存规范和埃塞俄比亚Silt'e区Dalocha区初级保健机构的疫苗冷链管理做法
IF 3.1 Q3 INFECTIOUS DISEASES Pub Date : 2022-04-20 DOI: 10.1186/s40794-022-00167-5
Diriba Feyisa, Fikadu Ejeta, Temesgen Aferu, Oliyad Kebede
{"title":"Adherence to WHO vaccine storage codes and vaccine cold chain management practices at primary healthcare facilities in Dalocha District of Silt'e Zone, Ethiopia","authors":"Diriba Feyisa, Fikadu Ejeta, Temesgen Aferu, Oliyad Kebede","doi":"10.1186/s40794-022-00167-5","DOIUrl":"https://doi.org/10.1186/s40794-022-00167-5","url":null,"abstract":"","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":" ","pages":""},"PeriodicalIF":3.1,"publicationDate":"2022-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43831973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
期刊
Tropical Diseases, Travel Medicine and Vaccines
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1